https://www.selleckchem.com/products/OSI-930.html
Endemic systemic mycoses remain a health challenge, since these opportunistic diseases are increasingly infecting immunosuppressed patients. The simultaneous use of antifungal compounds and other drugs to treat infectious or non-infectious diseases has led to several interactions and undesirable effects. Thus, new antifungal compounds should be investigated. The present study aimed to evaluate the activity of liriodenine extracted from on agents of systemic mycoses, with emphasis on the genus . The minimum inhibitory concentration (MIC)
Like
Comment
Share
